Beranda1099 • HKG
add
Sinopharm Group Co Ltd
Tutup sebelumnya
$20,50
Rentang hari
$20,35 - $20,70
Rentang tahun
$16,02 - $23,65
Kapitalisasi pasar
64,13Â M HKD
Volume Rata-Rata
4,93Â jt
Rasio P/E
6,94
Hasil dividen
4,65%
Bursa utama
HKG
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CNY) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 147,36Â M | -5,19% |
Biaya operasional | 6,78Â M | 4,18% |
Laba bersih | 1,85Â M | -26,34% |
Margin laba bersih | 1,26 | -22,22% |
Penghasilan per saham | — | — |
EBITDA | 4,76Â M | -25,05% |
Tarif pajak efektif | 22,34% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 43,33Â M | 26,05% |
Total aset | 429,58Â M | 2,85% |
Total liabilitas | 307,15Â M | 0,84% |
Total ekuitas | 122,43 M | — |
Saham yang beredar | 3,12 M | — |
Harga terhadap nilai buku | 0,85 | — |
Tingkat pengembalian aset | 2,44% | — |
Tingkat pengembalian modal | 4,69% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 1,85Â M | -26,34% |
Kas dari operasi | -20,50Â M | -678,47% |
Kas dari investasi | -519,26Â jt | -167,92% |
Kas dari pembiayaan | 10,78Â M | 5.713,58% |
Perubahan kas bersih | -10,24Â M | -512,13% |
Arus kas bebas | 2,71Â M | 108,45% |
Tentang
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Didirikan
2003
Situs
Karyawan
113.635
